New Targeted Therapy Options for ER Positive, HER2 Negative, Advanced Breast Cancer

Precision Oncology specialist, Alex Rolland, discusses new targeted therapy options for premenopausal women with ER+ HER2- advanced breast cancer. While the standard of care treatment is still chemotherapy, these new targeted treatments offer certain patients much better results while avoiding chemo entirely.

Alex explains the results of a recent study, called the RIGHT Choice Trial, which showed excellent PFS (Progression-Free Survival) rates – not just at the 12 month mark, but at the two year mark! He also shares the key takeaways that premenopausal women with ER+ HER2- advanced breast cancer need to know about this new treatment combination protocol.

He is joined by Precision Oncology Advocate and CTOAM cofounder, Michelle Morand. They also share next steps to take to find out if this new protocol will work for you and how to access it.

00:00 Introduction
00:16 Alex’s Presentation: The Sunset For Chemo? Targeted Therapy For Premenopausal Women With ER Positive, HER2 Negative Advanced Breast Cancer
02:27 What is the current standard of care treatment?
03:47 New treatments that are offering better success rates (without chemo)
04:32 Critical information about these new treatment options
06:33 Understanding the RIGHT Choice Trial
08:38 Exploring the results of the RIGHT Choice Trial
10:41 Why PFS (Progression-Free Survival) rates are so important
13:01 Comparing side effects: standard treatment vs. new treatments
17:56 Conclusions and takeaways for patients based on the study results
18:55 How to get the information and support you need now

If you’d like to identify the most effective treatment for your cancer, and how to access it as soon as possible (and through your current treatment team) reach out to us and book a consult using the link below 👇

➡️ For a Personalized Treatment Options Review with specialist Alex Rolland and his team, book a Precision Second Opinion: https://www.ctoam.com/consultation 🩺

***

Other ways to learn more about your cancer care options:

➡️ Book a free introductory call with Michelle to learn more about how precision cancer medicine works and how it may benefit you: https://www.ctoam.com/free-strategy-s...

➡️ How to access new treatments through your current doctor?
Join our (free) online Self-Advocacy training program: https://help.ctoam.com/just-the-facts


-

CTOAM is a worldwide, Canadian-based personalized cancer care and precision oncology service specializing in getting our client's rapid access to the best possible cancer treatment available for their form of cancer, while assisting their physicians in having the most current data from which to make confident treatment decisions on your behalf.

We facilitate access to peer-reviewed, science-based precision diagnostics such as PET/CT scans, liquid biopsy (blood-based genetic tests) and detailed genetic panels. We use these leading diagnostic tools, combined with a thorough and personalized research review, as our team explores the most advanced scientific data available today to find the best options for you.

Other ways to stay in touch with CTOAM:

Facebook:   / cancertreatmentoptionsandmanagement  
LinkedIn:   / ctoam  
Twitter:   / ctoam  
Blog: https://research.ctoam.com/


LinkedIn (Liquid Biopsy Labs):   / 13063544  
LBL Twitter:   / liquidbiopsynow  


Disclaimer:

Please understand that these videos are meant for educational purposes only. These videos are not intended to diagnose or be used as treatment advice. Viewers are encouraged to speak with their doctor or healthcare professionals for medical advice and before making any changes to their healthcare based on this information. All statements made in this video regarding medical treatments and health conditions are sourced and have been approved by the U.S. Food and Drug Administration (FDA). Watching this video is not a substitute for professional medical advice or a diagnosis.